Insud Pharma
Paloma Romero Hernández has a strong background in tax and finance, with experience spanning over two decades. Paloma currently holds the position of Tax & Finance Director at Insud Pharma since 2023. Prior to this, Paloma worked as a Tax Director at Bolt from 2021 to 2023. Paloma also had a long tenure at Insud Pharma, where they served as Tax & Statutory Reporting Director from 2014 to 2021. Before joining Insud Pharma, Paloma gained valuable experience at EY as a Business Tax Advisory from 2008 to 2014, and at KPMG España as an M&A TAX specialist from 2001 to 2008.
Paloma Romero Hernández completed a Bachelor's Degree in Business Administration and Management, General from the Universidad de Valladolid from 1995 to 2000. Paloma later pursued a Master's Degree in Tax Law/Taxation from IE Business School in 2000-2001. In 1998-1999, Paloma also attended the University of Birmingham to study Business Administration and Management, General. Recently, in 2016-2017, they participated in the Corporate Development Program at IESE Business School.
This person is not in the org chart
This person is not in any offices
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.